| Particulars |
|
|
|
| Company Name
| Emcure Pharmaceuticals Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
189.56 |
B.V. (₹) |
169.50 |
| Sales(₹ Cr.) |
4,381.92 |
NP (₹ Cr.) |
288.59 |
| NP Var (%) |
78.00 |
Div% |
30.00 |
| CPS(₹) |
27.10 |
EPS (₹) |
15.20 |
| Traded Value(₹ Lakhs) |
2,844.25 |
52 Week High |
1,525.00 |
| 52 Week Low |
890.00 |
Price BSE |
1,385.00 |
| Price NSE |
1,385.00 |
Market Capital (₹ Cr.) |
26,262.31 |
| P/C Ratio |
51.10 |
P/E Ratio |
91.00 |
| Price Vs.BV |
8.17 |
|
| Latest Quarter |
| Year End |
202509 |
Sales (₹ Cr.) |
1,260.60 |
| NP(₹ Cr.) |
117.62 |
NP Var % |
35.00 |
| Trailing Twelve Months |
| Year End |
202509 |
Sales |
3,847.63 |
| OPM |
12.80 |
NP |
232.25 |
| NP Var (%) |
103.92 |
EPS |
22.83 |
| PE |
60.68 |
|
|